Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918216 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
Our risk adaptive target- and dose prescription concept of prescribing a lower dose to the whole gland and an escalated dose to the GTV using LDR-BT seed planning was technically feasible and resulted in a significant dose-reduction to urethra and bladder neck.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Susanne Rylander, Daniel Polders, Marcel J. Steggerda, Luc M. Moonen, Kari Tanderup, Uulke A. Van der Heide,